COVID-19 ile Olası İlişkili İnkomplet Kawasaki Hastalığı: Olgu Sunumu

Year 2021, Volume: 2 Issue: 2, 56 - 59, 25.08.2021

Muzaffer Altıntaş Engin Yurdakul Feyza Ayşenur Paç Meltem Refiker Ege

https://doi.org/10.51261/yiu.2021.00030

Abstract

Kawasaki hastalığı,sıklıkla 5 yaş altı çocukları etkileyen , orta ve küçük damarların tutulumu ile seyreden akut inflamatuar bir hastalıktır. SARS-CoV2 çocuklarda ciddi hastalığa neden olmasa da, hastalığın hızlı yayılması ile COVID-19’dan etkilenen çocuklarda Kawasakibenzeri hastalık gibi yeni klinik durumlar görülmeye başlamıştır. Bu makalede COVID-19 ile olası ilişkili olduğunu düşündüğümüz bir inkomplet Kawasaki olgusu sunduk.

Keywords

Kawasaki-benzeri hastalık , incomplete Kawasaki , SARS-CoV2 , COVID-19

Incomplete Kawasaki Disease Probable Associated with COVID-19: A Case Report

Abstract

Kawasaki disease is an acute systemic inflammatory disease affecting the medium and small vessels mostly in children under 5 years old. Although SARS-CoV2 less severely affects children, with the rapid spread of disease some new clinical aspects like Kawasaki-like disease have been reported in children affected by COVID-19. Here in we present a child with incomplete Kawasaki disease probably associated with COVID-19.

Keywords

Kawasaki-like disease , incomplete Kawasaki , SARSCoV2 , COVID-19

References

• Pouletty M, Borocco C, Ouldani N, Caseris M, Basmaci R, Lachaume N et al. Paediatric multisystem inflammatory syndrome temporally associated with SARS- COV-2 mimicking Kawasaki disease Kawa-COVID-19 : a multicentre cohort. Ann Rheum Dis. 2020;79:2.
• Verdoni L, Mazza A, Gervasoni A, Martelli L, Ruggeri M, Ciuffreda M et al. Anoutbreak of severe Kawasaki-like disease at Italian epicentre of the SARS- CoV-2 epidemic: an observational cohort study. Lancet. 2020 6-12; 395: 1771– 1778
• Kawasaki T. Proc Jpn Acad Ser B Phys Biol Sci. 2006; 82:59–71.
• Greco A, De Virglio A, Rizzo MI, Tombolini M, Gallo A, fusconi M, et al. Kawasaki disease an evolving paradigim. Autoimmun Rev 2015;14:703-9.
• JCS Joint Working Group, Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease JCS 2013 . Digest version Circ J. 2014;78:2521-62 .
• Mc Crindle BW, Rowley AH, Newburger JW al. Diagnosis, treatment and long-term management of Kawasaki disease: a scientefic statement for health professionals from the American heart association. Circulation 2017;135:104-7
• Sanchez-Manubens J, Bou R, Anton J. Diagnosis and classification of Kawasaki disease Autoimmun 2014;48-49:113-7
• Kato H. Cardiovascular complications in Kawasaki disease coronary artery lumen and long-term consequences. Progress Pediatr Cardiol 2004;19:137-45.
• Uehara R, Igarashi H, Yashiro M, Nakamura, Yanagawa H; Kawasaki disease patients with rednes or crust formation at the Bacille Calmette-Guérin inoculation site.The Pediatric İnfectious Disease Journal. 2010; 29:430-433.
• Feldstein LR, Rose EB, Horwitz SM, Collins JP, Newhams MM, Son MBF, et al. Multisystem inflammatory syndrome in US Children and adolescents. N Engl J Med. 2020;383:334–346. doi:10.1056/NEJ Moa 2021680
• Yang, Yang, et al. “Laboratory diagnosis and monitoring the viral shedding of 2019- nCoV infections.” medRxiv 2020 .
• Henderson LA, Canna SW, Friedman KG, Gorelik M, Lapidus SK, Bassiri H, et al. American College of Rheumatology Clinical Guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020 doi:10.1002/art.414
• Pascall B, Thakker A, Foo Y, Thakker P. Immunoglobulin for Kawasaki disease: a 3-year retrospective audit. BMJ Paediatrics Open 2019;3: E000451.
• Dajani AS, Taubert KA, Gerber MA, Shulman ST. Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:177680
• Wright DA, Newburger JW, Baker A, Sundel RP. Treatment of immune globulin-resistant Kawasaki disease with pulsed doses of corticosteroides. J Pediatr 1996; 128:146-9.